ALEXANDRIA, Va., Sept. 17 -- United States Patent no. 12,414,994, issued on Sept. 16, was assigned to DOUGLAS PHARMACEUTICALS Ltd. (Auckland, New Zealand).

"Compositions comprising lopinavir and treatment of conditions" was invented by Ian Hampson (Manchester Greater Manchester, Great Britain), Lynne Hampson (Manchester Greater Manchester, Great Britain), Fergus Cameron Binnie (Auckland, New Zealand) and Peter Surman (Auckland, New Zealand).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein are methods and compositions for treating and/or inhibiting the development or progression of conditions caused by, or associated with, Herpes Simplex Virus (HSV) infection. In particular, provided are composit...